Literature DB >> 9168223

Stellate ganglion block alleviates pseudo-obstruction symptoms followed by episodes of hypermetropia: case report.

J Devulder1, M De Laat, G Rolly.   

Abstract

BACKGROUND AND OBJECTIVES: The chronic intestinal pseudo-obstruction due to visceral myopathy is a disorder resembling bowel obstruction but without mechanical occlusion. Frequently, parenteral nutrition becomes the final palliative treatment. A patient affected with this syndrome for 16 years was suffering causalgic pain provoked by intraveneous perfusion. Stellate ganglion block was requested in the hope of maintaining the perfusion.
METHODS: Stellate ganglion block not only stopped the pain but unexpectedly, it temporarily relieved the pseudo-obstruction symptoms. Two radiofrequency coagulations in the stellate ganglion prolonged the beneficial effects on gastrointestinal transit for more than 3 weeks, after which the symptoms returned. Multidisciplinary and multicenter advice was that further destructive treatments not be attempted.
RESULTS: Repetitive stellate ganglion blocks with 2 mL of bupivacaine 0.75% restored gastrointestinal function for more than 3 weeks. However, after performance of radiofrequency coagulation, infiltration with bupivacaine was followed by hypermetropia on the right eye of 2 weeks duration.
CONCLUSIONS: The relationship between stellate ganglion block and gastrointestinal function has not been described. This case report does not provide sufficient information to recommend this technique for pseudo-obstruction symptoms. Moreover, the result in this case is a fortuitous observation, lacking a clear scientific explanation. Further study may be warranted.

Entities:  

Mesh:

Year:  1997        PMID: 9168223     DOI: 10.1016/s1098-7339(06)80016-7

Source DB:  PubMed          Journal:  Reg Anesth        ISSN: 0146-521X


  1 in total

Review 1.  Complications associated with stellate ganglion nerve block: a systematic review.

Authors:  Vasudha Goel; Amol M Patwardhan; Mohab Ibrahim; Carol L Howe; David M Schultz; Hariharan Shankar
Journal:  Reg Anesth Pain Med       Date:  2019-04-16       Impact factor: 5.564

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.